Diagnostic significance of allelic imbalance in cancer

Bibliography

• LENGAUER C, KINZLER KW, VOGELSTEIN B: Genetic instabilities in human cancers. Nature (1998) 396:643-649.
   PubMed Web of Science ®Google Scholar
• PAYNE SR, KEMP CJ: Tumor suppressor genetics. Carcinogenesis (2005) 6:2031-2045.
   Google Scholar
• HANAHAN D, WEINBERG RA: The hallmarks of cancer. Cell (2000) 100:57-70.
   PubMed Web of Science ®Google Scholar
• MITELMAN F, JOHANSSON B, MANDAHL N, MERTENS F: Clinical significance of cytogenetic findings in solid tumors. Cancer Genet. Cytogenet. (1997) 95:1-8.
   PubMed Web of Science ®Google Scholar
• CIBAS ES: Applications of flow cytometric DNA analysis to diagnostic cytology. Diagn. Cytopathol. (1995) 13:166-171.
   PubMed Web of Science ®Google Scholar
• NEDERLOF PM, ROBINSON D, ABUKNESHA R et al.: Three-color fluorescence in situ hybridization for the simultaneous detection of multiple nucleic acid sequences. Cytometry (1989) 10:20-27.
   PubMedGoogle Scholar
• NEDERLOF PM, VAN DER FLIER S, RAAP AK et al.: Detection of chromosome aberrations in interphase tumor nuclei by nonradioactive in situ hybridization. Cancer Genet. Cytogenet. (1989) 42:87-98.
   PubMed Web of Science ®Google Scholar
• PIETERS MH, GERAEDTS JP, MEYER H et al.: Human gametes and zygotes studied by nonradioactive in situ hybridization. Cytogenet. Cell Genet. (1990) 53:15-19.
   PubMedGoogle Scholar
• NEDERLOF PM, VAN DER FLIER S, WIEGANT J et al.: Multiple fluorescence in situ hybridization. Cytometry (1990) 11:126-131.
   PubMedGoogle Scholar
• WIEGANT J, RIED T, NEDERLOF PM, VAN DER PLOEG M, TANKE HJ, RAAP AK: In situ hybridization with fluoresceinated DNA. Nucleic Acids Res. (1991) 19:3237-3241.
   PubMed Web of Science ®Google Scholar
• LE BEAU MM: One FISH, two FISH, red FISH, blue FISH. Nat. Genet. (1996) 12:341-344.
   PubMed Web of Science ®Google Scholar
• JIN L, LLOYD RV: In situ hybridization: methods and applications. J. Clin. Lab. Anal. (1997) 11:2-9.
   PubMed Web of Science ®Google Scholar
• LE BEAU MM: Fluorescence in situ hybridization in cancer diagnosis. Import. Adv. Oncol. (1993):29-45.
   PubMedGoogle Scholar
• KEARNEY L: Multiplex-FISH (M-FISH): technique, developments and applications. Cytogenet. Genome Res. (2006) 114:189-198.
   PubMed Web of Science ®Google Scholar
• SCHROCK E, DU MANOIR S, VELDMAN T et al.: Multicolor spectral karyotyping of human chromosomes. Science (1996) 273:494-497.
   PubMed Web of Science ®Google Scholar
• TSUDA H: HER-2 (c-erbB-2) test update: present status and problems. Breast Cancer (2006) 13:236-248.
   PubMedGoogle Scholar
• BUBENDORF L, GRILLI B, SAUTER G, MIHATSCH MJ, GASSER TC, DALQUEN P: Multiprobe FISH for enhanced detection of bladder cancer in voided urine specimens and bladder washings. Am. J. Clin. Pathol. (2001) 116:79-86.
   PubMed Web of Science ®Google Scholar
• HALLING KC, KING W, SOKOLOVA IA et al.: A comparison of BTA stat, hemoglobin dipstick, telomerase and Vysis UroVysion assays for the detection of urothelial carcinoma in urine. J. Urol. (2002) 167:2001-2006.
   PubMed Web of Science ®Google Scholar
• SAROSDY MF, SCHELLHAMMER P, BOKINSKY G et al.: Clinical evaluation of a multi-target fluorescent in situ hybridization assay for detection of bladder cancer. J. Urol. (2002) 168:1950-1954.
   PubMed Web of Science ®Google Scholar
• SOKOLOVA IA, HALLING KC, JENKINS RB et al.: The development of a multitarget, multicolor fluorescence in situ hybridization assay for the detection of urothelial carcinoma in urine. J. Mol. Diagn. (2000) 2:116-123.
   PubMed Web of Science ®Google Scholar
• ARENTSEN HC, DE LA ROSETTE JJ, DE REIJKE TM, LANGBEIN S: Fluorescence in situ hybridization: a multitarget approach in diagnosis and management of urothelial cancer. Expert Rev. Mol. Diagn. (2007) 7:11-19.
   PubMed Web of Science ®Google Scholar
• BLACK PC, BROWN GA, DINNEY CP: Molecular markers of urothelial cancer and their use in the monitoring of superficial urothelial cancer. J. Clin. Oncol. (2006) 24:5528-5535.
   PubMed Web of Science ®Google Scholar
• RAJAGOPALAN H, NOWAK MA, VOGELSTEIN B, LENGAUER C: The significance of unstable chromosomes in colorectal cancer. Nat. Rev. Cancer (2003) 3:695-701.
   PubMed Web of Science ®Google Scholar
• GRADE M, BECKER H, LIERSCH T, RIED T, GHADIMI BM: Molecular cytogenetics: genomic imbalances in colorectal cancer and their clinical impact. Cell Oncol. (2006) 28:71-84.
   PubMed Web of Science ®Google Scholar
• OZAKYOL A, OZDEMIR M, ARTAN S: Fish detected p53 deletion and N-MYC amplification in colorectal cancer. Hepatogastroenterology (2006) 53:192-195.
   PubMed Web of Science ®Google Scholar
• OOI A, TAKEHANA T, LI X et al.: Protein overexpression and gene amplification of HER-2 and EGFR in colorectal cancers: an immunohistochemical and fluorescent in situ hybridization study. Mod. Pathol. (2004) 17:895-904.
   PubMed Web of Science ®Google Scholar
• KURZROCK R, KANTARJIAN HM, DRUKER BJ, TALPAZ M: Philadelphia chromosome-positive leukemias: from basic mechanisms to molecular therapeutics. Ann. Intern. Med. (2003) 138:819-830.
   PubMed Web of Science ®Google Scholar
• LANDSTROM AP, TEFFERI A: Fluorescent in situ hybridization in the diagnosis, prognosis, and treatment monitoring of chronic myeloid leukemia. Leuk. Lymphoma (2006) 47:397-402.
   PubMed Web of Science ®Google Scholar
• FEHM T, SOLOMAYER EF, MENG S et al.: Methods for isolating circulating epithelial cells and criteria for their classification as carcinoma cells. Cytotherapy (2005) 7:171-185.
   PubMed Web of Science ®Google Scholar
• QIAN J, JENKINS RB, BOSTWICK DG: Genetic and chromosomal alterations in prostatic intraepithelial neoplasia and carcinoma detected by fluorescence in situ hybridization. Eur. Urol. (1999) 35:479-483.
   PubMed Web of Science ®Google Scholar
• TSUCHIYA N, SLEZAK JM, LIEBER MM, BERGSTRALH EJ, JENKINS RB: Clinical significance of alterations of chromosome 8 detected by fluorescence in situ hybridization analysis in pathologic organ-confined prostate cancer. Genes Chromosomes Cancer (2002) 34:363-371.
   PubMed Web of Science ®Google Scholar
• LI R, TODD NW, QIU Q et al.: Genetic deletions in sputum as diagnostic markers for early detection of stage I non-small cell lung cancer. Clin. Cancer Res. (2007) 13:482-487.
   PubMed Web of Science ®Google Scholar
• KALLIONIEMI A, KALLIONIEMI OP, SUDAR D et al.: Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science (1992) 258:818-821.
   PubMed Web of Science ®Google Scholar
• KALLIONIEMI OP, KALLIONIEMI A, SUDAR D et al.: Comparative genomic hybridization: a rapid new method for detecting and mapping DNA amplification in tumors. Semin. Cancer Biol. (1993) 4:41-46.
   PubMed Web of Science ®Google Scholar
• GEBHART E: Comparative genomic hybridization (CGH): ten years of substantial progress in human solid tumor molecular cytogenetics. Cytogenet. Genome Res. (2004) 104:352-358.
   PubMed Web of Science ®Google Scholar
• PATEL AS, HAWKINS AL, GRIFFIN CA: Cytogenetics and cancer. Curr. Opin. Oncol. (2000) 12:62-67.
   PubMed Web of Science ®Google Scholar
• GEBHART E: Genomic imbalances in human leukemia and lymphoma detected by comparative genomic hybridization. Int. J. Oncol. (2005) 27:593-606.
   PubMed Web of Science ®Google Scholar
• PINKEL D, SEGRAVES R, SUDAR D et al.: High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat. Genet. (1998) 20:207-211.
   PubMed Web of Science ®Google Scholar
• VAN BEERS EH, NEDERLOF PM: Array-CGH and breast cancer. Breast Cancer Res. (2006) 8:210.
   PubMed Web of Science ®Google Scholar
• ALBERTSON DG: Profiling breast cancer by array CGH. Breast Cancer Res. Treat. (2003) 78:289-298.
   PubMed Web of Science ®Google Scholar
• SUN J, LIU W, ADAMS TS et al.: DNA copy number alterations in prostate cancers: a combined analysis of published CGH studies. Prostate (2007) 67:692-700.
   PubMed Web of Science ®Google Scholar
• KLOTH JN, OOSTING J, VAN WEZEL T et al.: Combined array-comparative genomic hybridization and single-nucleotide polymorphism – loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer. BMC Genomics (2007) 8:53.
   PubMed Web of Science ®Google Scholar
• CHEN W, HOULDSWORTH J, OLSHEN AB et al.: Array comparative genomic hybridization reveals genomic copy number changes associated with outcome in diffuse large B-cell lymphomas. Blood (2006) 107:2477-2485.
   PubMed Web of Science ®Google Scholar
• HOSOYA N, SANADA M, NANNYA Y et al.: Genomewide screening of DNA copy number changes in chronic myelogenous leukemia with the use of high-resolution array-based comparative genomic hybridization. Genes Chromosomes Cancer (2006) 45:482-494.
   PubMed Web of Science ®Google Scholar
• TYYBÄKINOJA A, ELONEN E, PIIPPO K, PORKKA K, KNUUTILA S: Oligonucleotide array-CGH reveals cryptic gene copy number alterations in karyotypically normal acute myeloid leukemia. Leukemia (2007) 21:571-574.
   PubMed Web of Science ®Google Scholar
• BERGAMASCHI A, KIM YH, WANG P et al.: Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer. Genes Chromosomes Cancer (2006) 45:1033-1040.
   PubMed Web of Science ®Google Scholar
• CLARK J, EDWARDS S, FEBER A et al.: Genome-wide screening for complete genetic loss in prostate cancer by comparative hybridization onto cDNA microarrays. Oncogene (2003) 22:1247-1252.
   PubMed Web of Science ®Google Scholar
• YLSTRA B, VAN DEN IJSSEL P, CARVALHO B, BRAKENHOFF RH, MEIJER GA: BAC to the future! or oligonucleotides: a perspective for micro array comparative genomic hybridization (array CGH). Nucleic Acids Res. (2006) 34:445-450.
   PubMed Web of Science ®Google Scholar
• BEJJANI BA, SHAFFER LG: Application of array-based comparative genomic hybridization to clinical diagnostics. J. Mol. Diagn. (2006) 8:528-533.
   PubMed Web of Science ®Google Scholar
• JONSSON G, NAYLOR TL, VALLON-CHRISTERSSON J et al.: Distinct genomic profiles in hereditary breast tumors identified by array-based comparative genomic hybridization. Cancer Res. (2005) 65:7612-7621.
   PubMed Web of Science ®Google Scholar
• FRIDLYAND J, SNIJDERS AM, YLSTRA B et al.: Breast tumor copy number aberration phenotypes and genomic instability. BMC Cancer (2006) 6:96.
   PubMed Web of Science ®Google Scholar
• VANDEN BEMPT I, VANHENTENRIJK V, DRIJKONINGEN M, DE WOLF-PEETERS C: Comparative expressed sequence hybridization reveals differential gene expression in morphological breast cancer subtypes. J. Pathol. (2006) 208:486-494.
   PubMed Web of Science ®Google Scholar
• VAN BEERS EH, VAN WELSEM T, WESSELS LF et al.: Comparative genomic hybridization profiles in human BRCA1 and BRCA2 breast tumors highlight differential sets of genomic aberrations. Cancer Res. (2005) 65:822-827.
   PubMed Web of Science ®Google Scholar
• WESSELS LF, VAN WELSEM T, HART AA, VANT VEER LJ, REINDERS MJ, NEDERLOF PM: Molecular classification of breast carcinomas by comparative genomic hybridization: a specific somatic genetic profile for BRCA1 tumors. Cancer Res. (2002) 62:7110-7117.
   PubMed Web of Science ®Google Scholar
• JOHANNSDOTTIR HK, JONSSON G, JOHANNESDOTTIR G et al.: Chromosome 5 imbalance mapping in breast tumors from BRCA1 and BRCA2 mutation carriers and sporadic breast tumors. Int. J. Cancer (2006) 119:1052-1060.
   PubMed Web of Science ®Google Scholar
• YANO S, MATSUYAMA H, MATSUDA K, MATSUMOTO H, YOSHIHIRO S, NAITO K: Accuracy of an array comparative genomic hybridization (CGH) technique in detecting DNA copy number aberrations: comparison with conventional CGH and loss of heterozygosity analysis in prostate cancer. Cancer Genet. Cytogenet. (2004) 150:122-127.
   PubMed Web of Science ®Google Scholar
• VAN DEKKEN H, PARIS PL, ALBERTSON DG et al.: Evaluation of genetic patterns in different tumor areas of intermediate-grade prostatic adenocarcinomas by high-resolution genomic array analysis. Genes Chromosomes Cancer (2004) 39:249-256.
   PubMed Web of Science ®Google Scholar
• CLARK J, EDWARDS S, FEBER A et al.: Genome-wide screening for complete genetic loss in prostate cancer by comparative hybridization onto cDNA microarrays. Oncogene (2003) 22:1247-1252.
   PubMed Web of Science ®Google Scholar
• PETERSEN I, PETERSEN S: Towards a genetic-based classification of human lung cancer. Anal. Cell Pathol. (2001) 22:111-121.
   PubMedGoogle Scholar
• CONSTANTINOU M, BINKA-KOWALSKA A, BORKOWSKA E et al.: Application of multiplex FISH, CGH and MSSCP techniques for cytogenetic and molecular analysis of transitional cell carcinoma (TCC) cells in voided urine specimens. J. Appl. Genet. (2006) 47:273-275.
   PubMed Web of Science ®Google Scholar
• BIGNELL GR, HUANG J, GRESHOCK J et al.: High-resolution analysis of DNA copy number using oligonucleotide microarrays. Genome Res. (2004) 14:287-295.
   PubMed Web of Science ®Google Scholar
• HUANG J, WEI W, ZHANG J et al.: Whole genome DNA copy number changes identified by high density oligonucleotide arrays. Hum. Genomics (2004) 1:287-299.
   PubMedGoogle Scholar
• RAUCH A, RUSCHENDORF F, HUANG J et al.: Molecular karyotyping using an SNP array for genomewide genotyping. J. Med. Genet. (2004) 41:916-922.
   PubMed Web of Science ®Google Scholar
• ZHAO X, LI C, PAEZ JG et al.: An integrated view of copy number and allelic alterations in the cancer genome using single nucleotide polymorphism arrays. Cancer Res. (2004) 64:3060-3071.
   PubMed Web of Science ®Google Scholar
• KOED K, WIUF C, CHRISTENSEN LL et al.: High-density single nucleotide polymorphism array defines novel stage and location-dependent allelic imbalances in human bladder tumors. Cancer Res. (2005) 65:34-45.
   PubMed Web of Science ®Google Scholar
• DUTT A, BEROUKHIM R: Single nucleotide polymorphism array analysis of cancer. Curr. Opin. Oncol. (2007) 19:43-49.
   PubMed Web of Science ®Google Scholar
• LIEBERFARB ME, LIN M, LECHPAMMER M et al.: Genome-wide loss of heterozygosity analysis from laser capture microdissected prostate cancer using single nucleotide polymorphic allele (SNP) arrays and a novel bioinformatics platform dChipSNP. Cancer Res. (2003) 63:4781-4785.
   PubMed Web of Science ®Google Scholar
• LIPS EH, DIERSSEN JW, VAN EIJK R et al.: Reliable high-throughput genotyping and loss-of-heterozygosity detection in formalin-fixed, paraffin-embedded tumors using single nucleotide polymorphism arrays. Cancer Res. (2005) 65:10188-10191.
   PubMed Web of Science ®Google Scholar
• WONG KK, TSANG YT, CHANG YM et al.: Genome-wide allelic imbalance analysis of pediatric gliomas by single nucleotide polymorphic allele array. Cancer Res. (2006) 66:11172-11178.
   PubMed Web of Science ®Google Scholar
• HU N, WANG C, HU Y et al.: Genome-wide loss of heterozygosity and copy number alteration in esophageal squamous cell carcinoma using the Affymetrix GeneChip Mapping 10K array. BMC Genomics (2006) 7:299.
   PubMedGoogle Scholar
• TORRING N, BORRE M, SORENSEN KD, ANDERSEN CL, WIUF C, ORNTOFT TF: Genome-wide analysis of allelic imbalance in prostate cancer using the Affymetrix 50K SNP mapping array. Br. J. Cancer (2007) 96:499-506.
   PubMed Web of Science ®Google Scholar
• WANG ZC, BURAIMOH A, IGLEHART JD, RICHARDSON AL: Genome-wide analysis for loss of heterozygosity in primary and recurrent phyllodes tumor and fibroadenoma of breast using single nucleotide polymorphism arrays. Breast Cancer Res. Treat. (2006) 97:301-309.
   PubMed Web of Science ®Google Scholar
• IRVING JA, BLOODWORTH L, BOWN NP, CASE MC, HOGARTH LA, HALL AG: Loss of heterozygosity in childhood acute lymphoblastic leukemia detected by genome-wide microarray single nucleotide polymorphism analysis. Cancer Res. (2005) 65:3053-3058.
   PubMed Web of Science ®Google Scholar
• PFEIFER D, PANTIC M, SKATULLA I et al.: Genome-wide analysis of DNA copy number changes and LOH in CLL using high-density SNP arrays. Blood (2007) 109:1202-1210.
   PubMed Web of Science ®Google Scholar
• TSENG RC, CHANG JW, HSIEN FJ et al.: Genomewide loss of heterozygosity and its clinical associations in non small cell lung cancer. Int. J. Cancer (2005) 117:241-247.
   PubMed Web of Science ®Google Scholar
• ELLSWORTH RE, ELLSWORTH DL, LUBERT SM, HOOKE J, SOMIARI RI, SHRIVER CD: High-throughput loss of heterozygosity mapping in 26 commonly deleted regions in breast cancer. Cancer Epidemiol. Biomarkers Prev. (2003) 12:915-919.
   PubMed Web of Science ®Google Scholar
• ELLSWORTH RE, ELLSWORTH DL, DEYARMIN B et al.: Timing of critical genetic changes in human breast disease. Ann. Surg. Oncol. (2005) 12:1054-1060.
   PubMed Web of Science ®Google Scholar
• ELLSWORTH RE, HOOKE JA, LOVE B et al.: Correlation of levels and patterns of genomic instability with histological grading of invasive breast tumors. Breast Cancer Res. Treat. (2007) (In Press).
   Google Scholar
• HEAPHY CM, HINES WC, BUTLER KS et al.: Assessment of the frequency of allelic imbalance in human tissue using a multiplex polymerase chain reaction system. J. Mol. Diagn. (2007) 9:266-271.
   PubMed Web of Science ®Google Scholar
• FRIGERIO S, PADBERG BC, STREBEL RT et al.: Improved detection of bladder carcinoma cells in voided urine by standardized microsatellite analysis. Int. J. Cancer (2007) 121:329-338.
   PubMed Web of Science ®Google Scholar
• SCHWARZENBACH H, CHUN FK, LANGE I et al.: Detection of tumor-specific DNA in blood and bone marrow plasma from patients with prostate cancer. Int. J. Cancer (2007) 120:1465-1471.
   PubMed Web of Science ®Google Scholar
• WANG YC, HSU HS, CHEN TP, CHEN JT: Molecular diagnostic markers for lung cancer in sputum and plasma. Ann. NY Acad. Sci. (2006) 1075:179-184.
   PubMed Web of Science ®Google Scholar
• IAFRATE AJ, FEUK L, RIVERA MN et al.: Detection of large-scale variation in the human genome. Nat. Genet. (2004) 36:949-951.
   PubMed Web of Science ®Google Scholar
• SEBAT J, LAKSHMI B, TROGE J et al.: Large-scale copy number polymorphism in the human genome. Science (2004) 305:525-528.
   PubMed Web of Science ®Google Scholar